The coronavirus fear caused yet another horrific day for trading as the ASX plummeted by 4.2%. It is safe to say that the 11-year bull run following the GFC is now over. In turn, investors must take precautions as we experience an unpleasant bearish decline.… Read more
A silver lining in the current bearish decline is the opportunity to possibly enter strong stocks like Paradigm Biopharmaceuticals (ASX: PAR). PAR is one of Australia’s most talked-about biotechs of 2019 and 2020 so far.